Two groups of adult male Munich-Wistar rats and a third group of nondiabetic age-matched and weight-matched normal control rats underwent micropuncture study 1 mo, and morphologic studies 14 mo, after induction of streptozotocin diabetes or sham treatment. All animals were fed standard rat chow. Diabetic rats received daily ultralente insulin to maintain stable moderate hyperglycemia (-350 mg/dl). In addition, one group of diabetic rats was treated with the angiotensin I converting enzyme inhibitor, enalapril, 15 mg/liter of drinking water. Average kidney weight, whole kidney and single-nephron glomerular filtration rate, and glomerular plasma flow rate were elevated to similar values in both groups of diabetic rats, relative to normal control rats. Non-enalapril-treated diabetic rats exhibited significant elevations in mean glomerular capillary hydraulic pressure and transcapillary hydraulic pressure gradient, compared with the other groups studied, and only this group eventually developed marked and progressive albuminuria. Likewise, histological examination of the kidneys at 14 mo disclosed a high incidence of glomerular structural abnormalities only in non-enalapril-treated diabetic rats. These findings indicate that prevention of glomerular capillary hypertension in rats with diabetes mellitus effectively protects against the subsequekit development of glomerular structural injury and proteinuria. This protection is afforded despite pronounced hyperglycemia and elevated levels of glucosylated hemoglobin, further supporting our view that hemodynamic rather than metabolic factors predominate in the pathogenesis of diabetic glomerulopathy.
Introduction
A state ofglomerular hyperfiltration has been consistently demonstrated in patients with newly diagnosed insulin-dependent (Type I) diabetes mellitus (DM)' (1) (2) (3) (4) , as well as in the early 1. Abbreviations used in this paper: AP, glomerular transcapillary hydraulic pressure difference; 7A, systemic plasma colloid osmotic pressure; stages of experimental diabetes in animals (5) (6) (7) . In the latter, this hyperfiltration has been shown to result from concomitant elevations in glomerular plasma flow rate (QA) and mean glomerular capillary hydraulic pressure (5) (6) (7) . These early glomerular hemodynamic abnormalities have been implicated in the pathogenesis of the glomerulopathy that eventually develops in this disorder (8, 9) . We have shown previously (7) that in rats with diabetes induced by streptozotocin (STZ), dietary protein restriction limits both early elevations in glomerular pressures and flows and the subsequent development ofglomerular structural injury. Moreover, glomerular structural injury can be effectively prevented despite pronounced hyperglycemia as long as glomerular pressures and flows are maintained within normal limits. These findings provide strong evidence that hemodynamic, rather than metabolic, factors play a fundamental role in the initiation and progression of diabetic glomerulopathy.
Limitation of glomerular hemodynamic alterations has also been shown to prevent glomerular injury in rats subjected to severe renal ablation. Hostetter and co-workers (10) showed that dietary protein restriction normalizes glomerular hemodynamics and completely arrests glomerular injury in rats following 11/ 12 renal ablation. More recently, Anderson and co-workers (1 1), using rats with 5/6 renal ablation, demonstrated that treatment with the potent angiotensin I converting enzyme inhibitor, enalapril, not only restores systemic arterial pressure to normal levels but also selectively normalizes mean glomerular capillary hydraulic pressure. 8 wk after renal ablation, enalapril-treated rats exhibited a striking attenuation of glomerular structural injury, thus strengthening the possibility that glomerular hemodynamic abnormalities, and in particular elevations in glomerular pressures, also play a key role in the pathogenesis ofdiabetic glomerulopathy.
Systemic hypertension has been demonstrated to worsen, while antihypertensive therapy ameliorates, the progression of established diabetic glomerulopathy (12) (13) (14) . However, administration of antihypertensive therapy to normotensive diabetic patients has never been attempted as a prophylactic measure against glomerular disease. Since the kidneys of diabetic subjects exhibit marked vasodilation, it seems likely that even slight reductions in systemic arterial pressure would reduce glomerular AP, mean arterial pressure under anesthesia at time of micropuncture study; C, control; DM, diabetes mellitus; DM+E, insulin-treated rats also receiving enalapril; GFR, glomerular filtration rate; HbA,,, glucosylated hemoglobin; Kf, glomerular capillary ultrafiltration coefficient; LKW, left kidney weight; PAS, periodic acid Schiff; PGc, mean glomerular capillary hydraulic pressure; QA, glomerular plasma flow rate; RA, afferent arteriolar resistance; RE, efferent arteriolar resistance; RT, total arteriolar resistance; SBP, systolic blood pressure determined directly from the femoral artery under anesthesia at time of micropuncture study; SNFF, single-nephron filtration fraction; SNGFR, single-nephron glomerular filtration rate; STZ, streptozotocin; TBP, awake systolic blood pressure measured by tail cuff; U1b -V, urinary albumin excretion rate. 16 diabetic rats and 7 control rats underwent micropuncture study 4-6 wk after STZ injection. Blood glucose concentration was measured shortly before the beginning of each experiment and a few rats with values below 200 mg/dl were excluded from micropuncture study. Additional determinations made throughout the duration of these studies verified the persistence of moderate hyperglycemia (300-400 mg/dl). Rats were anesthetized with Inactin (100 mg/kg) and prepared for micropuncture as described previously (16). To replace plasma losses associated with anesthesia and surgery (17), isoncotic homologous plasma obtained from normal rats, equivalent to 1% body weight in volume, was infused over 50-60 min, followed by a sustaining infusion of 0.8-1.0 ml/h throughout the rest of the experiment. Inulin, 10 g/100 ml in normal saline, was also infused at a rate of 1.2 ml/h. Samples of tubule fluid were obtained from superficial proximal tubules for determinations of flow rate and inulin concentration. The latter was measured by the method of Vurek and Pegram (18) . Blood samples were obtained from surface efferent arterioles for determination of total protein concentration as described previously (16, 19) . Hydraulic pressures were measured in superficial cortical tubules and microvessels by the servo-null technique (16) . Details of the calculations employed are given elsewhere (16).
Rats in each group not subjected to micropuncture study were maintained at similar stable levels of moderate hyperglycemia by daily ultralente insulin treatment for 14 mo after induction ofdiabetes. 24-h urinary albumin excretion rates were determined at alternate monthly intervals by the single radial immunodiffusion technique (20). Systolic blood pressures were also measured by tail cuff(TBP) at biweekly intervals in these conscious rats. At the end of this 14-mo period, rats were anesthetized with nembutal (50 mg/kg i.p.) and 150 md of blood were collected for determination of glucosylated hemoglobin levels (21) . Kidneys were then fixed by perfusion at the measured arterial pressure for 2-3 min with 1.25% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4).
Morphology. After perfusion fixation, the weight of the left kidney was recorded and two midcoronal slices of tissue, 2-3-mm thick, were processed for light microscopic examination. 3-Mm-thick paraffin sections were stained with hematoxylin and eosin and by the periodic acid Schiff (PAS) reaction. The extent of the glomerular damage was determined on PAS-stained slides by counting on two sections all glomerular profiles with segmental or global collapse of capillaries with or without associated hyalin deposition and adhesion of the tuft to Bowman's capsule. The number ofglomeruli with segmental or global obsolescence ofcapillaries was expressed as a percentage of all glomerular profiles counted in the histologic sections. Structural alterations at the level of the tubules, interstitium, and blood vessels were assessed qualitatively. Statistics. Statistical analysis was performed by one-way analysis of variance followed by Bonferroni's procedure for multiple pairwise comparisons (22).
Results
Micropuncture experiments. Values for systemic hemodynamic and whole kidney function 4-6 wk after STZ injection are presented in Table I (mean± 1 SEM). Both enalapril-treated (DM+E) and untreated (DM) diabetic rats exhibited body weights nearly identical to those of normal control rats. Blood glucose concentration determined immediately before micropuncture was moderately elevated as compared with controls (87±3 mg/dl) in both DM (350±11 mg/dl) and DM+E (346±14 mg/dl) rats. Systolic blood pressure determined directly from the femoral artery (SBP) at the time ofthe experiment was similar in control (C) and DM rats and did not differ from previously measured awake tail-cuff blood pressures (TBP) in either group (Fig. 1) (Table I) .
Results concerning glomerular hemodynamics are summarized in Table II and Fig. 2 . As with GFR, the average value for single-nephron glomerular filtration rate (SNGFR) was markedly increased in DM rats (81.6±5.7 nl/min vs. 45.9±3.8 nl/min in controls, P < 0.01). This elevation in SNGFR was associated with a proportional increase in QA (269±26 nl/min vs. 154±18 nl/min in controls, P < 0.01), hence constancy of single-nephron filtration fraction, SNFF. Since AP was virtually identical in DM and C groups, the increase in QA must have resulted from renal arteriolar vasodilatation. Afferent (RA), efferent (RE), and total (RT = RA + RE) arteriolar resistances were indeed markedly decreased in DM rats relative to controls. However, the observed fall in RA was more pronounced than in RE, resulting in a decrease in the ratio RA/RT. In consequence, mean glomerular capillary hydraulic pressure (Pcc) and the glomerular transcapillary hydraulic pressure difference (AP) were Enalapril-treated (DM+E) rats also exhibited a significant increase in LKW as compared with controls (1.31±0.04 g vs. 1 .09±0.03 g, P < 0.05, Table I ). However, this hypertrophy was not as marked as in DM rats (P < 0.05 DM vs. DM+E). GFR and SNGFR were numerically, though not significantly, lower in DM+E when compared with DM rats. Since RT in DM+E rats was comparable to the average value obtained in DM rats, and given a moderate reduction in AP, QA was also slightly, but not significantly, diminished in this group relative to DM rats. As a result of the reduction in AP and a slight decrement in RE, AP was markedly decreased in DM+E as compared with DM rats; in fact, AP achieved complete normalization in DM+E animals (37±1 mmHg vs. 39±1 mmHg in controls). A unique value for Kf could be calculated in every experiment; no significant differences in this parameter were seen among the three groups studied, although DM+E rats tended to have higher values (Table II) .
Long-term studies. Results obtained for body weight, LKW (after perfusion-fixation with glutaraldehyde), glucosylated hemoglobin (HbAI), and 24-h urinary albumin excretion rate (U,b V) at 14 mo after induction of diabetes are summarized in Table III . Body weights were moderately lower in DM and DM+E rats as compared with controls. As observed at 4-6 wk of diabetes, LKW was markedly increased in DM rats as compared with controls (2.60±0.10 g vs. 1.85±0.10 g, P < 0.05), indicating persistence ofrenal hypertrophy throughout the study. Renal hypertrophy of slightly lesser magnitude was observed in the DM+E group.
As shown in Fig. 1 , a state of stable moderate hyperglycemia was maintained throughout the duration of the experiment in both diabetic groups. That the metabolic derangement was similar in both diabetic groups is further illustrated by the finding in Table III (Fig. 1) . Albumin excretion increased with time in DM rats, U,b *V rising on average to 11 1±22 mg/24 h at 14 mo ofdiabetes ( Fig. 3 and Table III Morphologic findings. A total of 501 glomerular profiles on average were examined and graded per animal. Segmental collapse of the glomerular tuft was observed in over 6% of glomerular profiles at 14 mo in untreated diabetic animals (6.06%±1.20). The comparable frequencies ofglomerular lesions in enalapril-treated diabetic animals and controls were 0.67±0.20% and 1.10±0.18%, respectively (Table III) . Untreated diabetic animals, in addition, showed focal dilatation ofproximal convoluted tubules and the presence of occasional casts in the distal segments ofthe nephron. Focal tubule atrophy with minor nonspecific round cell infiltration and fibrosis ofthe interstitium was often seen in association with obsolescent glomeruli in this group. In contrast, control animals and enalapril-treated diabetic rats had only minimal disruption ofthe tubules and interstitium. Vascular changes were not prominent in any of the groups.
Discussion
Sustained hyperfiltration has been demonstrated in early phases of insulin-dependent human diabetes and in animal models, before diabetic microvascular disease has become evident. Hostetter and co-workers (5) showed that this hyperfiltration was the result of concomitant elevations in glomerular plasma flow rate and mean glomerular transcapillary hydraulic pressure difference. Several studies have suggested that these hemodynamic abnormalities are key factors in the initiation and progression of diabetic glomerulopathy (7, 23, 24) . Recently, Zatz et studied moderately hyperglycemic STZ-diabetic rats 1 and 12 mo after induction of diabetes. Wide variations in glomerular hemodynamics were intentionally induced by feeding diets containing 50, 12, or 6% casein (standard commercial rat chow contains 21-24% protein). Only rats receiving the protein-rich (50%) diet exhibited elevated glomerular pressures and flows at 1 mo of diabetes. Despite comparable metabolic abnormalities in all three diabetic groups, only the group on the highest protein diet developed substantial glomerular injury 12 mo after induction of diabetes. When glomerular hemodynamic abnormalities were attenuated by moderate (12%) or more marked (6%) dietary protein restriction, glomerular structural injury was largely prevented. These studies clearly underscore the importance ofearly elevation of glomerular pressures and flows in the subsequent development of glomerular injury in this model.
In this study, diabetic rats receiving standard 24% protein chow exhibited glomerular hemodynamic alterations resembling those previously observed in diabetic rats fed a 50% protein diet, and those previously reported by Hostetter et al. (5) . As in these previous studies, a marked decrease in glomerular arteriolar resistances, in particular RA, was associated with corresponding elevations in QA, AP, and SNGFR. In the current study, glomerular hemodynamic alterations were attenuated by converting enzyme inhibition rather than by restricting dietary protein intake. This maneuver has been shown previously in this laboratory ( 11) Thus, the observed differences between DM and DM+E groups regarding glomerular morphology cannot be attributed to differences in metabolic control; rather, the structural differences appear to result solely from the observed differences in glomerular hemodynamics, and in particular the differences in AP in the two groups. In this regard, the present findings closely resemble those previously obtained by Zatz and co-workers (7), in that only the group sustaining early glomerular hypertension eventually developed widespread glomerular injury at 14 mo of diabetes. The precise mechanism(s) whereby intracapillary hypertension adversely affects glomerular structure has not been elucidated. Systemic arterial hypertension has long been known to increase arterial and arteriolar permeability to macromolecular tracers and to lead to structural damage of arterial walls (9, (26) (27) (28) . Elevations in intracapillary hydraulic pressures are likely to exert an analogous effect. In systemic capillaries, evidence for an association between capillary basement membrane thickness and capillary pressure has been provided in a number of situations, including variation of intravascular hydrostatic pressure by gravity (29), local venous stasis (30) , and long-standing congestive heart failure (31). One possible mechanism for this effect could be the stimulation of local basement membrane production by the increased capillary wall tension, in a manner analogous to the enhanced collagen synthesis observed with increased local tension in other tissues (32) . At the glomerular capillary level, this tension could also lead to direct mechanical disruption ofthe glomerular capillary wall, giving rise to capillary microaneurysms and epithelial cell detachment from the glomerular basement membrane (28, 33). Furthermore, the increased platelet aggregability observed in diabetes (34) might further contribute to the development of diabetic glomerular injury by promoting capillary thrombosis in the presence of even minor degrees of endothelial injury. This possibility is strengthened by the observation of a protective effect of heparin against glomerular injury in the remnant kidney (35) (39, 40) .
Clinical studies have shown that treatment of systemic hypertension in patients with moderately advanced diabetic nephropathy retards subsequent deterioration of renal function, presumably by ameliorating abnormal glomerular capillary hemodynamics (13, 14) . The present study demonstrates for the first time that long-term converting enzyme inhibition in an animal model of diabetes mellitus not only delays, but actually prevents, the establishment of diabetic glomerulopathy, largely by normalizing glomerular capillary hydraulic pressure.
